In Brief: Cordis CrossFlex
This article was originally published in The Gray Sheet
Executive Summary
Cordis CrossFlex: Results of a 329 patient study of the tantalum coronary stent, presented at a Sept. 24 session of the Transcatheter Cardiovascular Therapeutics meeting in Washington, D.C., demonstrate a 41% restenosis rate for the 3.0 mm version, 11% for the 3.5 mm size and 5% for the 4.0 mm model, stated investigator Seung-Jung Park, MD, Asan Medical Center, Seoul, Korea. The device is currently available in international markets ("The Gray Sheet" July 21, I&W-8)...
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.